Dr. Frishberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6010 Hidden Valley Rd
Ste 200
Carlsbad, CA 92011Phone+1 760-631-3000Fax+1 760-631-3016
Summary
- Dr. Benjamin Frishberg is a Neurologist based in Carlsbad, CA, specializing in Neuro-Ophthalmology. Headache Medicine, and neuroimmunology/multiple sclerosis. He completed medical school at University Minnesota and went on to do Internal medicine and Neurology Residencyat University of California San Diego before his Neuro-Ophthalmology fellowship at Emory University in Atlanta. He is now a senior clinician at the neurology Center of Southern California where he has been for the past 27 years. He now acts as the director of clinical research as well as being active inpatient care. He has held academic positions at Howard University, Georgetown University, George Washington University and is now Clinical Professor of Neuroscience at UCSD (voluntary).. Dr. Frishberg has been Principal Investigator in over 50 clinical studies in Neurology going back 30 years an continues to contribute to the literature, is a reviewer for multiple journals, and continues to lecture nationally on his topics of expertise.
Education & Training
- Emory University School of MedicineFellowship, Neuro-Ophthalmology, 1984 - 1985
- University of California (San Diego) Medical CenterResidency, Neurology, 1981 - 1984
- La Jolla Veterans Administration1984
- University of California (San Diego) Medical CenterResidency, Internal Medicine, 1980 - 1981
- University of California (San Diego) Medical CenterInternship, Internal Medicine, 1979 - 1980
- University of Minnesota Medical SchoolClass of 1979
- University of MinnesotaBS, Physiological Psychology, Summa Cum Laude, 1974
Certifications & Licensure
- CA State Medical License 1997 - 2027
- DC State Medical License 1985 - 1998
- MD State Medical License 1985 - 1998
- GA State Medical License 1984 - 1985
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Best Doctors San Diego, 2003-2005, 2012, 2023
- Fellow North American Neuro-Ophthalmology Society 1995
- Fellow American Academy of Neurology, 1994
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsMesenchymal Stromal Cell Implants for Chronic Motor Deficits After Traumatic Brain Injury: Post Hoc Analysis of a Randomized Trial.David O Okonkwo, Peter McAllister, Achal S Achrol, Yasuaki Karasawa, Masahito Kawabori
Neurology. 2024-10-08 - Not just any headache.Janet Fan, Pamela Davila, Noor Laylani, Andrew G Lee, Benjamin Frishberg
Survey of Ophthalmology. 2023-10-27 - 3 citationsConsensus Statement on Visual Rehabilitation in Mild Traumatic Brain Injury.Prem S Subramanian, Jason J S Barton, Paul Ranalli, Craig Smith, Courtney E Francis
Neurology. Clinical Practice. 2022-12-01
Journal Articles
- Consensus Statement on the Use of Botulinum Neurotoxin to Treat Spasticity in Adults.Thomas L. Davis, MD, Matthew A. Brodsky, MD, Victoria A. Carter, MD, Marc DiFazio, MD, Ben Frishberg, MD, Eugene C. Lai, MD, PhD, John McGuire, MD, Douglas P. Meyer, R..., P&T 31;666-682
- Program to Assess Headache Treatmetn Strategies: An Observational Study of Botulinum Toxin Type A in the Preventive Treatmetn of Migraine.Stephen D. Silberstein, MD; Alexander Mauskop, MD; Benjamin M. Frishberg, MD; Stewart J. Tepper, MD; Peter McAllister, MD; Sheena K. Aurora, MD Frederick G. Freitag, DO, Headache. 2006; 46: 846
- Frishberg et al Long-term Safety and Tolerability of a Fixed Single-Tablet Formulation of Sumatriptan RT Technology and Naproxen Sodium in the Acute Treatment of Migra...Paul Winner, DO, Roger K. Cady, MD; Gary E. Ruoff, Benjamin M, Headache. 2006; 46:859-860
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Predictors of Outcomes of Botulinum Toxin Type A in the Preventive Treatment of Headache.Stephen D. Silberstein, MD; Alexander Mauskop, MD; Benjamin M. Frishberg, MD; Stewart J. Tepper, MD; Peter McAllister, MD; Sheena K. Aurora, MD Frederick G. Freitag, DO, Migraine Trust Meeting, London
- MBA§ Botulinum Toxin Type A for the Prophylaxis of Chronic Daily Headache in Migraineurs: A Randomized, Double-Blind, Placebo Controlled Trial.Ninan T. Mathew, MD,† Benjamin M. Frishberg, MD,* Marek Gawel, MB, BCh, FRCPC,‡ Ronald DeGryse, MS, MA,§ Catherine Turkel, PharmD, European Federation of Neurologic Societies meeting
- A New Formulation of Dihydroergotamine (DHE) is Effective for Sustained Relief in the Acute Treatment of Migraine.Frishberg, BM, Headache 43:5, 525, Abstract F17
- Join now to see all
Lectures
- Efficacy of the Triptans.Merck Regional Consultants Meeting, Williamsburg, VA
- Treatment Options in MS.San Diego Chapter, National Multiple Sclerosis Society
- Treatment of Spasticity.San Diego Chapter, National Multiple Sclerosis Society
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: